Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Université de Montréal

$105,000.00

The neuromuscular function as a diagnostic tool and a therapeutic target in an ALS mouse model

FY 2016-17

Summary
Amyotrophic lateral sclerosis is a neurodegenerative disease leading to muscle weakness, paralysis, and usually death by respiratory failure in about 2 to 5 years after the diagnosis. In ALS, the specific connection between the motor neuron and the muscle, namely the neuromuscular junction (NMJ), which is responsible for the production of movements, is progressively destroyed. The motor message is therefore unable to be sent to the muscle, so voluntary movements become more and more difficult to produce. In my doctoral project, I try to understand how this specific connection is lost during the disease process and what is the role of the various actors at the NMJ. Specifically, I focus my research on the three components of the NMJ : the muscle, the motor neuron, and a specific type of glial cells at the NMJ, the perisynaptic Schwann cells. I will first try to understand how muscle function and strength is affected during the disease process in a mouse model of the disease. Then, I will also try to test drugs previously identified as having possibly a therapeutic potential at the NMJ, to try to rescue the various alterations in synaptic transmission and NMJ function identified. Finally, I will try to unravel the role of glial cells malfunctions at the NMJ, which could play a role in the disease process. These efforts may provide a better understanding of the pathogenesis of ALS and may help to develop a potential NMJ-targeted treatment for ALS.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
365529
Name
Tremblay Elsa
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The neuromuscular function as a diagnostic tool and a therapeutic target in an ALS mouse model
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Calcium Imaging; Electrophysiology; Fiber Type; Glia; Immunohistochemistry; Motor Unit; Neuromuscular Junction; Perisynaptic Schwann Cells; Synaptic Plasticity
Abstract
Amyotrophic lateral sclerosis is a neurodegenerative disease leading to muscle weakness, paralysis, and usually death by respiratory failure in about 2 to 5 years after the diagnosis. In ALS, the specific connection between the motor neuron and the muscle, namely the neuromuscular junction (NMJ), which is responsible for the production of movements, is progressively destroyed. The motor message is therefore unable to be sent to the muscle, so voluntary movements become more and more difficult to produce. In my doctoral project, I try to understand how this specific connection is lost during the disease process and what is the role of the various actors at the NMJ. Specifically, I focus my research on the three components of the NMJ : the muscle, the motor neuron, and a specific type of glial cells at the NMJ, the perisynaptic Schwann cells. I will first try to understand how muscle function and strength is affected during the disease process in a mouse model of the disease. Then, I will also try to test drugs previously identified as having possibly a therapeutic potential at the NMJ, to try to rescue the various alterations in synaptic transmission and NMJ function identified. Finally, I will try to unravel the role of glial cells malfunctions at the NMJ, which could play a role in the disease process. These efforts may provide a better understanding of the pathogenesis of ALS and may help to develop a potential NMJ-targeted treatment for ALS.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tremblay, Elsa
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
Université de Montréal - $105,000 Grant (2016-17) | Canada Spends